Mirae Asset Global Investments
AVIR icon

Mirae Asset Global Investments’s Atea Pharmaceuticals AVIR Stock Holding History

Mirae Asset Global Investments’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Sell
3,579
-496
-12% -$2.47K ﹤0.01% 1510
2026
Q1 		$21.9K Buy
4,075
+279
+7% +$1.28K ﹤0.01% 1420
2025
Q4 		$13.6K Buy
3,796
+728
+24% +$2.31K ﹤0.01% 1585
2025
Q3 		$8.9K Sell
3,068
-238
-7% -$813 ﹤0.01% 1588
2025
Q2 		$11.9K Buy
3,306
+480
+17% +$1.43K ﹤0.01% 1468
2025
Q1 		$8.28K Buy
2,826
+11
+0.4% +$34 ﹤0.01% 1487
2024
Q4 		$9.37K Sell
2,815
-238
-8% -$791 ﹤0.01% 1519
2024
Q3 		$10.5K Buy
3,053
+538
+21% +$1.95K ﹤0.01% 1494
2024
Q2 		$8.5K Sell
2,515
-27,950
-92% -$104K ﹤0.01% 1470
2024
Q1 		$97.3K Buy
+30,465
New +$119K ﹤0.01% 2373
2023
Q4 		– Sell
-29,926
Closed -$89.8K – 2531
2023
Q3 		$89.8K Buy
29,926
+73
+0.2% +$248 ﹤0.01% 2483
2023
Q2 		$112K Sell
29,853
-170
-0.6% -$636 ﹤0.01% 2480
2023
Q1 		$101K Sell
30,023
-52
-0.2% -$211 ﹤0.01% 2445
2022
Q4 		$145K Buy
30,075
+30
+0.1% +$152 ﹤0.01% 2380
2022
Q3 		$171K Buy
30,045
+9,644
+47% +$73.8K ﹤0.01% 2386
2022
Q2 		$145K Buy
+20,401
New +$139K ﹤0.01% 2240

Other funds holding AVIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AI
Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mirae Asset Global Investments's AVIR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Atea Pharmaceuticals (AVIR) stake by 12% in Q2 2026, selling an estimated $2.47K and leaving 3,579 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Mirae Asset Global Investments first reported a position in AVIR in Q2 2022 and has held it in 16 quarters since. The position peaked at $171K in Q3 2022. 40 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Mirae Asset Global Investments held 3,579 shares of Atea Pharmaceuticals worth $16.6K as of Q2 2026.
  • Mirae Asset Global Investments sold 496 Atea Pharmaceuticals shares in Q2 2026, an estimated $2.47K.
  • Atea Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1510 holding.
  • Mirae Asset Global Investments first reported a position in Atea Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Atea Pharmaceuticals position peaked at $171K in Q3 2022.
  • 40 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.